776
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Study Design and Interim Outcomes of Guangzhou Institute of Respiratory Disease COPD Biobank

, , , , , , , , , , , , , , , , , , , , , , , , , , & show all

References

  • Global Strategy for Diagnosis, Management, and Prevention of COPD, Updated 2009. [http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=2003] (accessed January 2015).
  • Wedzicha JA. The heterogeneity of chronic obstructive pulmonary disease. Thorax 2000; 55(8):631–632.
  • Agusti AG. COPD, a multicomponent disease: implications for management. Respir Med 2005; 99(6):670–682.
  • Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11:122.
  • Kim V, Han MK, Vance GB, Make BJ, Newell, Hokanson JE, Hersh CP, Stinson D, Silverman EK, Criner GJ, COPDGene Investigators. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest 2011; 140(3):626–633.
  • Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010; 7(1):32–43.
  • Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing–1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000; 161(1):309–329.
  • Quanjer PH, Pretto JJ, Brazzale DJ, Boros PW. Grading the severity of airways obstruction: new wine in new bottles. Eur Respir J 2014; 43(2):505–512.
  • Ferris BG. Epidemiology Standardization Project (American Thoracic Society). Am Rev Respir Dis 1978; 118(6 Pt 2):1–120.
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi A, Coates R, Crapo P, Enright P, van der Grinten CPM, Gustafsson P, Jensen R, Johnson N, MacIntyre R, McKay D, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. Standardisation of spirometry. Eur Respir J 2005; 26(2):319–338.
  • Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, Enright PL, Hankinson JL, Ip MS, Zheng J, Stocks J, ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40(6):1324–1343.
  • Zhang Z, Wang J, He J, Zheng Z, Zeng X, Zhang C, Ye J, Zhang Y, Zhong N, Lu W. Genetic variants in MUC4 gene are associated with lung cancer risk in a Chinese population. PLoS One 2013; 8(10):e77723.
  • Pillai SG, Ge D, Zhu G, Kong X, Shianna KV, Need AC, Feng S, Hersh CP, Bakke P, Gulsvik A, Ruppert A, Lodrup Carlsen KC, Roses, A, Anderson W, Rennard SI, Lomas DA, Silverman EK, Goldstein DB, ICGN Investigators. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009; 5(3):e1000421.
  • Wilk JB, Chen TH, Gottlieb DJ, Walter RE, Nagle MW, Brandler BJ, Myers RH, Borecki IB, Silverman EK, Weiss ST, O'Connor GT. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet 2009; 5(3):e1000429.
  • Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J 2007; 30(5):993–1013.
  • Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barns PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187(4):347–365.
  • Ko FW, Lim TK, Hancox RJ, Yang IA. Year in review 2013: Chronic obstructive pulmonary disease, asthma and airway biology. Respirology 2014; 19(3):438–447.
  • Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005; 128(4):2099–2107.
  • Crisafulli E, Costi S, Luppi F, Cirelli G, Cilione C, Coletti O, Fabbri LM, Clini EM. Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation. Thorax 2008; 63(6):487–492.
  • van Eeden SF, Sin DD. Chronic obstructive pulmonary disease: a chronic systemic inflammatory disease. Respiration 2008; 75(2):224–238.
  • Ito K, Barnes PJ. COPD as a disease of accelerated lung aging. Chest 2009; 135(1):173–180.
  • De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 2006; 80(3):219–227.
  • Mannino DM, Thorn D, Swensen A, Holguin F. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008; 32(4):962–969.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.